These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21461992)

  • 1. Immunotherapy with pluripotent stem cell-derived dendritic cells.
    Senju S; Matsunaga Y; Fukushima S; Hirata S; Motomura Y; Fukuma D; Matsuyoshi H; Nishimura Y
    Semin Immunopathol; 2011 Nov; 33(6):603-12. PubMed ID: 21461992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pluripotent stem cells as source of dendritic cells for immune therapy.
    Senju S; Hirata S; Motomura Y; Fukuma D; Matsunaga Y; Fukushima S; Matsuyoshi H; Nishimura Y
    Int J Hematol; 2010 Apr; 91(3):392-400. PubMed ID: 20155337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pluripotent stem cell-derived dendritic cells for immunotherapy.
    Senju S; Matsunaga Y; Fukushima S; Hirata S; Matsuyoshi H; Nishimura Y
    Front Biosci (Elite Ed); 2010 Jun; 2(4):1520-7. PubMed ID: 20515823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of mouse pluripotent stem cell-derived proliferating myeloid cells as an unlimited source of functional antigen-presenting cells.
    Zhang R; Liu TY; Senju S; Haruta M; Hirosawa N; Suzuki M; Tatsumi M; Ueda N; Maki H; Nakatsuka R; Matsuoka Y; Sasaki Y; Tsuzuki S; Nakanishi H; Araki R; Abe M; Akatsuka Y; Sakamoto Y; Sonoda Y; Nishimura Y; Kuzushima K; Uemura Y
    Cancer Immunol Res; 2015 Jun; 3(6):668-77. PubMed ID: 25672396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple antigen-targeted immunotherapy with alpha-galactosylceramide-loaded and genetically engineered dendritic cells derived from embryonic stem cells.
    Fukushima S; Hirata S; Motomura Y; Fukuma D; Matsunaga Y; Ikuta Y; Ikeda T; Kageshita T; Ihn H; Nishimura Y; Senju S
    J Immunother; 2009 Apr; 32(3):219-31. PubMed ID: 19242378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of antigen-specific cytotoxic T lymphocytes by beta 2-microglobulin or TAP1 gene disruption and the introduction of recipient-matched MHC class I gene in allogeneic embryonic stem cell-derived dendritic cells.
    Matsunaga Y; Fukuma D; Hirata S; Fukushima S; Haruta M; Ikeda T; Negishi I; Nishimura Y; Senju S
    J Immunol; 2008 Nov; 181(9):6635-43. PubMed ID: 18941254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breaking immunotolerance of tumors: a new perspective for dendritic cell therapy.
    Rolinski J; Hus I
    J Immunotoxicol; 2014 Oct; 11(4):311-8. PubMed ID: 24495309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cancer immunotherapy by utilizing dedritic cells derived from pluripotent stem cells].
    Fukushima S; Ihn H; Nishimura Y; Senju S
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(3):113-20. PubMed ID: 21720099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced priming of antigen-specific CTLs in vivo by embryonic stem cell-derived dendritic cells expressing chemokine along with antigenic protein: application to antitumor vaccination.
    Matsuyoshi H; Senju S; Hirata S; Yoshitake Y; Uemura Y; Nishimura Y
    J Immunol; 2004 Jan; 172(2):776-86. PubMed ID: 14707047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Vaccine Therapy Using Carcinoembryonic Antigen - expressing Dendritic Cells generated from Induced Pluripotent Stem Cells.
    Kitadani J; Ojima T; Iwamoto H; Tabata H; Nakamori M; Nakamura M; Hayata K; Katsuda M; Miyajima M; Yamaue H
    Sci Rep; 2018 Mar; 8(1):4569. PubMed ID: 29545628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenic Dendritic Cell Generation from Pluripotent Stem Cells by Ectopic Expression of Runx3.
    Takacs E; Boto P; Simo E; Csuth TI; Toth BM; Raveh-Amit H; Pap A; Kovács EG; Kobolak J; Benkö S; Dinnyes A; Szatmari I
    J Immunol; 2017 Jan; 198(1):239-248. PubMed ID: 27852743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells.
    André F; Chaput N; Schartz NE; Flament C; Aubert N; Bernard J; Lemonnier F; Raposo G; Escudier B; Hsu DH; Tursz T; Amigorena S; Angevin E; Zitvogel L
    J Immunol; 2004 Feb; 172(4):2126-36. PubMed ID: 14764678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Establishment of pluripotent stem cell-derived dendritic cells for clinical application].
    Senju S
    Rinsho Ketsueki; 2010 Nov; 51(11):1668-73. PubMed ID: 21157130
    [No Abstract]   [Full Text] [Related]  

  • 14. Dendritic cells and pluripotency: unlikely allies in the pursuit of immunotherapy.
    Fairchild PJ; Leishman A; Sachamitr P; Telfer C; Hackett S; Davies TJ
    Regen Med; 2015; 10(3):275-86. PubMed ID: 25933237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo.
    Stober D; Jomantaite I; Schirmbeck R; Reimann J
    J Immunol; 2003 Mar; 170(5):2540-8. PubMed ID: 12594280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1+ dendritic cells.
    Silk KM; Silk JD; Ichiryu N; Davies TJ; Nolan KF; Leishman AJ; Carpenter L; Watt SM; Cerundolo V; Fairchild PJ
    Gene Ther; 2012 Oct; 19(10):1035-40. PubMed ID: 22071967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently identified oncofetal antigen, induce protective immunity against highly metastatic mouse melanoma, B16-F10.
    Motomura Y; Senju S; Nakatsura T; Matsuyoshi H; Hirata S; Monji M; Komori H; Fukuma D; Baba H; Nishimura Y
    Cancer Res; 2006 Feb; 66(4):2414-22. PubMed ID: 16489048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of mesenchymal stem cells from human induced pluripotent stem cells on differentiation, maturation, and function of dendritic cells.
    Gao WX; Sun YQ; Shi J; Li CL; Fang SB; Wang D; Deng XQ; Wen W; Fu QL
    Stem Cell Res Ther; 2017 Mar; 8(1):48. PubMed ID: 28253916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo generation of interstitial and Langerhans cell-like dendritic cell subset-based vaccines for hematological malignancies.
    Hutten T; Thordardottir S; Hobo W; Hübel J; van der Waart AB; Cany J; Dolstra H; Hangalapura BN
    J Immunother; 2014 Jun; 37(5):267-77. PubMed ID: 24810638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient induction of specific cytotoxic T lymphocytes to tumor rejection peptide using functional matured 2 day-cultured dendritic cells derived from human monocytes.
    Tanaka F; Yamaguchi H; Haraguchi N; Mashino K; Ohta M; Inoue H; Mori M
    Int J Oncol; 2006 Nov; 29(5):1263-8. PubMed ID: 17016660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.